Frédéric Lagarce

3.3k total citations
69 papers, 2.7k citations indexed

About

Frédéric Lagarce is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Frédéric Lagarce has authored 69 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmaceutical Science, 20 papers in Molecular Biology and 16 papers in Biomaterials. Recurrent topics in Frédéric Lagarce's work include Nanoparticle-Based Drug Delivery (16 papers), Advanced Drug Delivery Systems (13 papers) and Drug Solubulity and Delivery Systems (12 papers). Frédéric Lagarce is often cited by papers focused on Nanoparticle-Based Drug Delivery (16 papers), Advanced Drug Delivery Systems (13 papers) and Drug Solubulity and Delivery Systems (12 papers). Frédéric Lagarce collaborates with scholars based in France, Belgium and Switzerland. Frédéric Lagarce's co-authors include Jean‐Pierre Benoît, Emilie Roger, Emmanuel Garcion, Anne Clavreul, Khaled Messaoudi, Anne‐Claire Groo, Fabienne Danhier, Guillaume Bastiat, Chiara Bastiancich and William Couet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Frédéric Lagarce

65 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Frédéric Lagarce 1.1k 937 905 451 368 69 2.7k
Ho Lun Wong 1.6k 1.4× 809 0.9× 1.7k 1.8× 959 2.1× 380 1.0× 40 3.5k
Hong Yuan 1.3k 1.2× 446 0.5× 435 0.5× 382 0.8× 327 0.9× 43 2.5k
Ashim K. Mitra 1.7k 1.5× 1.7k 1.8× 798 0.9× 445 1.0× 571 1.6× 135 4.8k
Yihui Deng 1.7k 1.5× 709 0.8× 1.1k 1.3× 849 1.9× 442 1.2× 134 4.2k
Luigi Battaglia 1.2k 1.1× 1.2k 1.2× 752 0.8× 437 1.0× 112 0.3× 75 2.7k
Wenquan Liang 1.4k 1.3× 645 0.7× 635 0.7× 346 0.8× 241 0.7× 124 2.9k
Giuseppina Bozzuto 1.1k 1.0× 309 0.3× 737 0.8× 490 1.1× 218 0.6× 35 2.4k
Susan R. Mallery 1.0k 0.9× 468 0.5× 348 0.4× 220 0.5× 309 0.8× 86 2.8k
Prabhat Ranjan Mishra 1.3k 1.2× 870 0.9× 891 1.0× 581 1.3× 335 0.9× 126 3.5k
Haibing He 996 0.9× 997 1.1× 932 1.0× 610 1.4× 271 0.7× 148 3.2k

Countries citing papers authored by Frédéric Lagarce

Since Specialization
Citations

This map shows the geographic impact of Frédéric Lagarce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Lagarce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Lagarce more than expected).

Fields of papers citing papers by Frédéric Lagarce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Lagarce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Lagarce. The network helps show where Frédéric Lagarce may publish in the future.

Co-authorship network of co-authors of Frédéric Lagarce

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Lagarce. A scholar is included among the top collaborators of Frédéric Lagarce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Lagarce. Frédéric Lagarce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roger, Emilie, et al.. (2024). Internalization and mechanisms of toxicity of lipid nanocapsules in HepG2 and HepaRG hepatoma cells upon acute and chronic exposures. International Journal of Pharmaceutics. 667(Pt A). 124815–124815.
2.
Legeay, Samuel, et al.. (2024). Elimination study of intact lipid nanocapsules after intravenous rat administration. Nanomedicine. 19(13). 1123–1131. 1 indexed citations
3.
Lagarce, Frédéric, Isabelle Roland, Denis Brossard, et al.. (2024). Recommendations on training objectives and staff qualification for the manual preparation of capsules in pharmacy. SHILAP Revista de lepidopterología. 9(1). 1 indexed citations
4.
Hilairet, Grégory, Jérôme Bejaud, Patrick Saulnier, et al.. (2022). Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique. Journal of Controlled Release. 351. 681–691. 16 indexed citations
5.
Legeay, Samuel, et al.. (2021). Specificity of pharmacokinetic modeling of nanomedicines. Drug Discovery Today. 26(10). 2259–2268. 16 indexed citations
6.
Lagarce, Frédéric. (2020). Nanomedicines: promises and reality. Drug Discovery Today. 25(3). 473–474. 2 indexed citations
7.
Vrignaud, Sandy, et al.. (2018). Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole. Journal de Mycologie Médicale. 28(2). 396–398. 13 indexed citations
8.
Lagarce, Frédéric. (2017). Centrally Prepared Cytotoxic Drugs: What Is the Purpose of Their Quality Control?. SHILAP Revista de lepidopterología. 2(1). 7 indexed citations
9.
Roger, Emilie, et al.. (2017). Models for drug absorption from the small intestine: where are we and where are we going?. Drug Discovery Today. 22(5). 761–775. 96 indexed citations
10.
Lagarce, Frédéric, et al.. (2016). Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials. SHILAP Revista de lepidopterología. 1(2). 3 indexed citations
11.
Lagarce, Frédéric & Catherine Passirani. (2016). Nucleic-Acid Delivery Using Lipid Nanocapsules. Current Pharmaceutical Biotechnology. 17(8). 723–727. 15 indexed citations
12.
Gimel, Jean-Christophe, et al.. (2016). How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?. Advanced Drug Delivery Reviews. 106(Pt B). 320–336. 87 indexed citations
13.
Lagarce, Frédéric, et al.. (2015). Is the translational approach becoming a reality in nanomedicine?. HAL (Le Centre pour la Communication Scientifique Directe). 7(2). 79–83. 3 indexed citations
14.
Lagarce, Frédéric. (2015). Nanomedicines: are we lost in translation?. HAL (Le Centre pour la Communication Scientifique Directe). 7(2). 77–78. 1 indexed citations
15.
Messaoudi, Khaled, et al.. (2015). Combined silencing expression of MGMT with EGFR or galectin-1 enhances the sensitivity of glioblastoma to temozolomide. HAL (Le Centre pour la Communication Scientifique Directe). 7(2). 97–107. 5 indexed citations
16.
Vrignaud, Sandy, et al.. (2015). Design and stability study of a paediatric oral solution of methotrexate 2mg/ml. International Journal of Pharmaceutics. 487(1-2). 270–273. 10 indexed citations
17.
Groo, Anne‐Claire, et al.. (2014). Development of 2D and 3D Mucus Models and Their Interactions with Mucus-Penetrating Paclitaxel-Loaded Lipid Nanocapsules. Pharmaceutical Research. 31(7). 1753–1765. 48 indexed citations
18.
Lagarce, Frédéric, et al.. (2014). Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide. International Journal of Nanomedicine. 9. 1479–1479. 36 indexed citations
19.
Thomas, Olivier, Nolwenn Lautram, Anne Clavreul, et al.. (2013). Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide. European Journal of Pharmaceutical Sciences. 50(2). 172–180. 43 indexed citations
20.
Roger, Emilie, Frédéric Lagarce, Emmanuel Garcion, & Jean‐Pierre Benoît. (2010). Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells. European Journal of Pharmaceutical Sciences. 40(5). 422–429. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ho Lun Wong Breakdown of academic impact, for papers by Hong Yuan Breakdown of academic impact, for papers by Ashim K. Mitra Breakdown of academic impact, for papers by Yihui Deng Breakdown of academic impact, for papers by Luigi Battaglia Breakdown of academic impact, for papers by Wenquan Liang Breakdown of academic impact, for papers by Giuseppina Bozzuto Breakdown of academic impact, for papers by Susan R. Mallery Breakdown of academic impact, for papers by Prabhat Ranjan Mishra Breakdown of academic impact, for papers by Haibing He
Rankless by CCL
2026